4.7 Article

ARPC1B promotes mesenchymal phenotype maintenance and radiotherapy resistance by blocking TRIM21-mediated degradation of IFI16 and HuR in glioma stem cells

Related references

Note: Only part of the references are listed.
Review Pharmacology & Pharmacy

The versatile role of HuR in Glioblastoma and its potential as a therapeutic target for a multi-pronged attack

Abhishek Guha et al.

Summary: Glioblastoma (GBM) is a malignant brain tumor characterized by treatment resistance due to cellular and molecular heterogeneity. Targeting HuR, a regulator of posttranscriptional RNA regulation, represents a plausible therapeutic strategy for attacking GBM.

ADVANCED DRUG DELIVERY REVIEWS (2022)

Article Oncology

Phase II study of ceralasertib (AZD6738) in combination with durvalumab in patients with advanced/metastatic melanoma who have failed prior anti-PD-1 therapy

R. Kim et al.

Summary: Ceralasertib in combination with durvalumab has promising antitumor activity among patients with metastatic melanoma who have failed anti-programmed cell death protein 1 therapy, and shows stable and sustained disease control rate.

ANNALS OF ONCOLOGY (2022)

Article Oncology

ATR Inhibitor AZD6738 (Ceralasertib) Exerts Antitumor Activity as a Monotherapy and in Combination with Chemotherapy and the PARP Inhibitor Olaparib

Zena Wilson et al.

Summary: AZD6738 is a potent ATR inhibitor that can be used as a monotherapy or in combination with chemotherapy or PARP inhibitors, showing high antitumor activity. The data from this study can provide a theoretical basis for the clinical use of ATR inhibitors in cancer treatment.

CANCER RESEARCH (2022)

Article Oncology

ATR inhibitor AZD6738 increases the sensitivity of colorectal cancer cells to 5-fluorouracil by inhibiting repair of DNA damage

Takuya Suzuki et al.

Summary: The combination of AZD6738 and 5-FU enhances the therapeutic effect on colorectal cancer cells, especially in those with p53 gene mutations.

ONCOLOGY REPORTS (2022)

Article Oncology

Dual role of ARPC1B in regulating the network between tumor-associated macrophages and tumor cells in glioblastoma

Tianqi Liu et al.

Summary: The tumor microenvironment (TME) plays a critical role in promoting the growth and metastasis of glioblastoma (GBM). Tumor-associated macrophages (TAMs), the most abundant myeloid cells infiltrating in TME, produce proinflammatory cytokines, regulate glioma cell pools, and lead to GBM progression. Understanding the mechanism of GBM-TAMs regulation can help to find new targeted therapeutic strategies against GBM. Based on the CGGA and TCGA GBM cohorts, ARPC1B was defined as the key macrophage-associated gene with prognostic value. Higher ARPC1B expression was associated with progressive malignancy, poor outcomes and TAM infiltration. We demonstrated that macrophage-expressed ARPC1B promoted the migration, invasion, and epithelial-mesenchymal transition of glioma cells. Glioma-intrinsic ARPC1B also maintained the malignant phenotype and promoted macrophage recruitment. Positive feedback signaling between macrophages and glioma cells via ARPC1B was determined to be under control of the IFN gamma-IRF2-ARPC1B axis. This study highlights the important role of ARPC1B in GBM malignancy progression and the regulation network between GBM and TAMs, suggesting ARPC1B as a novel biomarker with potential therapeutic implications.

ONCOIMMUNOLOGY (2022)

Article Genetics & Heredity

Novel Immune-Related Gene-Based Signature Characterizing an Inflamed Microenvironment Predicts Prognosis and Radiotherapy Efficacy in Glioblastoma

Hang Ji et al.

Summary: This study aimed to develop an immune-related gene (IRG) signature for predicting and improving the prognosis and treatment paradigm of glioblastoma (GBM). The IRG-based risk model showed superior prognostic performance and revealed the features of the immune microenvironment in the high-risk group, providing valuable information for clinical management.

FRONTIERS IN GENETICS (2022)

Article Oncology

Harnessing radiotherapy-induced NK-cell activity by combining DNA damage-response inhibition and immune checkpoint blockade

Emmanuel C. Patin et al.

Summary: This study identifies a role for NK cells in the antitumor immune response to radiotherapy that can be enhanced by small-molecule DNA damage-response inhibitors and immune checkpoint blockade, with promising translational potential in clinical samples.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2022)

Article Biochemistry & Molecular Biology

PRR11 induces filopodia formation and promotes cell motility via recruiting ARP2/3 complex in non-small cell lung cancer cells

Zhili Wei et al.

Summary: PRR11 participates in filopodia formation, focal adhesion turnover and cell motility in Non-Small Cell Lung Cancer cells through the ARP2/3 complex. Dysregulation of PRR11 expression may facilitate tumor metastasis.

GENES & DISEASES (2022)

Review Biochemistry & Molecular Biology

Protein domain-based approaches for the identification and prioritization of therapeutically actionable cancer variants

Elisabetta Grillo et al.

Summary: Computational approaches have been developed to prioritize cancer mutations based on their biological and clinical significance, with protein domain-based methods allowing the identification of functionally relevant low frequency variants. Prioritizing mutations based on clustered specific residues of protein domains could aid in choosing patient-specific targeted drugs and improving cancer patient management.

BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2021)

Article Oncology

Cell surface GRP78 regulates BACE2 via lysosome-dependent manner to maintain mesenchymal phenotype of glioma stem cells

Zihang Chen et al.

Summary: Surface expression of glucose-regulated protein 78 (csGRP78) was found to be preferentially expressed in MES GSCs, and targeting csGRP78 effectively suppressed self-renewal and radioresistance of MES GSCs both in vitro and in vivo by downregulating STAT3, NF-kappa B, and C/EBP beta pathways, potentially through regulation of downstream molecule BACE2. These findings suggest that blocking csGRP78 with a high-specificity antibody could be a promising therapeutic strategy for glioblastoma treatment.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2021)

Article Biochemistry & Molecular Biology

Hypoxia-induced PLOD1 overexpression contributes to the malignant phenotype of glioblastoma via NF-κB signaling

Zhenlin Wang et al.

Summary: PLOD1 is highly expressed in malignant tumors such as esophageal squamous cell carcinoma, gastric cancer, and colorectal cancer, particularly associated with the progression of the most malignant mesenchymal subtype in GBM. Molecular experiments and tumor xenograft models demonstrated that PLOD1 overexpression promotes tumor viability, proliferation, migration, and mesenchymal transition, with an association to the NF-kappa B signaling pathway. High PLOD1 expression may be a potential treatment target for mesenchymal GBM or even all GBM by enhancing tumor invasiveness.

ONCOGENE (2021)

Article Cell Biology

Molecular Basis of LH Action on Breast Cancer Cell Migration and Invasion via Kinase and Scaffold Proteins

Joselina Magali Mondaca et al.

Summary: Breast cancer, primarily hormone-dependent, may be influenced by the presence of luteinizing hormone (LH) in the body, which regulates cell migration and invasion through controlling various kinases. LH activates pathways that promote actin polymerization, essential for cell adhesion, migration, and invasion, ultimately enhancing metastatic spread of breast cancer cells.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)

Article Oncology

Phase I Study of Ceralasertib (AZD6738), a Novel DNA Damage Repair Agent, in Combination with Weekly Paclitaxel in Refractory Cancer

Seung Tae Kim et al.

Summary: Ceralasertib in combination with paclitaxel showed tolerability and antitumor activity in patients with advanced malignancies, with durable responses observed in advanced melanoma patients resistant to anti-PD1/L1 treatment.

CLINICAL CANCER RESEARCH (2021)

Article Oncology

SLFN11 biomarker status predicts response to lurbinectedin as a single agent and in combination with ATR inhibition in small cell lung cancer

Kiran Kundu et al.

Summary: The study identified SLFN11 as a potential biomarker for predicting sensitivity of SCLC to lurbinectedin, and combination therapy of lurbinectedin with ATR inhibitors may overcome resistance in SCLC cells with low SLFN11 expression.

TRANSLATIONAL LUNG CANCER RESEARCH (2021)

Article Cell Biology

Hypoxic glioma-derived exosomes promote M2-like macrophage polarization by enhancing autophagy induction

Jianye Xu et al.

Summary: The study reveals that glioma-derived exosomes may promote glioma proliferation and migration by inducing autophagy and M2-like macrophage polarization, leading to the formation of an immunosuppressive microenvironment. IL-6 and miR-155-3p could be novel biomarkers for diagnosing glioma, while treatments targeting autophagy and the STAT3 pathway may contribute to antitumor immunotherapy.

CELL DEATH & DISEASE (2021)

Article Oncology

Interactions between cancer cells and immune cells drive transitions to mesenchymal-like states in glioblastoma

Toshiro Hara et al.

Summary: The mesenchymal subtype of glioblastoma is believed to be influenced by both cancer cell-intrinsic alterations and external cellular interactions, with macrophages inducing a transition of glioblastoma cells into mesenchymal-like states. This transition is mediated by macrophage-derived oncostatin M (OSM) interacting with its receptors on glioblastoma cells, leading to the activation of STAT3. This study also reveals that mesenchymal-like glioblastoma states are associated with increased expression of a mesenchymal program in macrophages and enhanced cytotoxicity of T cells, suggesting potential therapeutic implications.

CANCER CELL (2021)

Editorial Material Oncology

ATR Inhibitors and Paclitaxel in Melanoma

Alan Ashworth

Summary: A phase I study found a tolerable combination of the ATR inhibitor ceralasertib with paclitaxel showed responses in melanoma patients who had progressed on an immune check-point inhibitor. Further exploration is needed to determine the extent and molecular determinants of clinical activity.

CLINICAL CANCER RESEARCH (2021)

Review Oncology

The 2021 WHO Classification of Tumors of the Central Nervous System: a summary

David N. Louis et al.

Summary: The fifth edition of the WHO Classification of Tumors of the Central Nervous System integrates molecular diagnostics into CNS tumor classification, introduces different approaches to tumor nomenclature and grading, and emphasizes the importance of integrated diagnoses and layered reports.

NEURO-ONCOLOGY (2021)

Article Immunology

A Comprehensive Prognostic and Immunological Analysis of a Six-Gene Signature Associated With Glycolysis and Immune Response in Uveal Melanoma

Jun Liu et al.

Summary: This study constructed a new prognostic gene signature for uveal melanoma patients, identifying glycolysis and immune response as main risk factors for overall survival. The six-gene signature showed good predictive efficiency and was validated in external cohorts, suggesting its potential as a therapeutic target for UM patients.

FRONTIERS IN IMMUNOLOGY (2021)

Editorial Material Oncology

Driving mesenchymal transition in glioblastoma

Michael Platten

NEURO-ONCOLOGY (2020)

Article Biochemistry & Molecular Biology

LOXL1 confers antiapoptosis and promotes gliomagenesis through stabilizing BAG2

Hua Yu et al.

CELL DEATH AND DIFFERENTIATION (2020)

Article Oncology

Cullin-7 (CUL7) is overexpressed in glioma cells and promotes tumorigenesis via NF-κB activation

Jianye Xu et al.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2020)

Review Oncology

Novel therapeutic strategies targeting telomere maintenance mechanisms in high-risk neuroblastoma

S. L. George et al.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2020)

Article Medicine, Research & Experimental

Hair follicle stem cell replication stress drives IFI16/STING-dependent inflammation in hidradenitis suppurativa

Cindy Orvain et al.

JOURNAL OF CLINICAL INVESTIGATION (2020)

Article Biochemistry & Molecular Biology

HPV E7 inhibits cell pyroptosis by promoting TRIM21-mediated degradation and ubiquitination of the IFI16 inflammasome

Yinjing Song et al.

INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2020)

Article Biochemistry & Molecular Biology

An Integrative Model of Cellular States, Plasticity, and Genetics for Glioblastoma

Cyril Neftel et al.

Article Multidisciplinary Sciences

HuR counteracts miR-330 to promote STAT3 translation during inflammation-induced muscle wasting

Souad Mubaid et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)

Review Pharmacology & Pharmacy

Current Challenges and Opportunities in Treating Glioblastoma

Andrea Shergalis et al.

PHARMACOLOGICAL REVIEWS (2018)

Review Pharmacology & Pharmacy

Targeting the replication stress response in cancer

Josep V. Forment et al.

PHARMACOLOGY & THERAPEUTICS (2018)

Review Physiology

THE Arp2/3 REGULATORY SYSTEM AND ITS DEREGULATION IN CANCER

Nicolas Molinie et al.

PHYSIOLOGICAL REVIEWS (2018)

Review Oncology

Targeting ATR in cancer

Emilio Lecona et al.

NATURE REVIEWS CANCER (2018)

Review Oncology

Advances in the molecular genetics of gliomas - implications for classification and therapy

Guido Reifenberger et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2017)

Article Biology

APOBEC3B and IL-6 form a positive feedback loop in hepatocellular carcinoma cells

Shuran Li et al.

SCIENCE CHINA-LIFE SCIENCES (2017)

Article Multidisciplinary Sciences

IFI16 and cGAS cooperate in the activation of STING during DNA sensing in human keratinocytes

Jessica F. Almine et al.

NATURE COMMUNICATIONS (2017)

Article Biochemistry & Molecular Biology

Vessel co-option mediates resistance to anti-angiogenic therapy in liver metastases

Sophia Frentzas et al.

NATURE MEDICINE (2016)

Article Biochemistry & Molecular Biology

Open Comet: An automated tool for comet assay image analysis

Benjamin M. Gyori et al.

REDOX BIOLOGY (2014)

Review Cell Biology

New insights into the regulation and cellular functions of the ARP2/3 complex

Jeremy D. Rotty et al.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2013)

Article Biochemistry & Molecular Biology

Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells

Wanjuan Yang et al.

NUCLEIC ACIDS RESEARCH (2013)

Article Multidisciplinary Sciences

A restricted cell population propagates glioblastoma growth after chemotherapy

Jian Chen et al.

NATURE (2012)

Article Cell Biology

The transcriptional coactivator TAZ regulates mesenchymal differentiation in malignant glioma

Krishna P. L. Bhat et al.

GENES & DEVELOPMENT (2011)

Article Multidisciplinary Sciences

The transcriptional network for mesenchymal transformation of brain tumours

Maria Stella Carro et al.

NATURE (2010)

Review Biochemistry & Molecular Biology

Regulation of HuR by DNA Damage Response Kinases

Hyeon Ho Kim et al.

JOURNAL OF NUCLEIC ACIDS (2010)

Review Cell Biology

ATR: an essential regulator of genome integrity

Karlene A. Cimprich et al.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2008)

Review Cell Biology

The ARP2/3 complex: an actin nucleator comes of age

Erin D. Goley et al.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2006)